Molecules-to-Medicine: Accelerating Drug Development through Collaboration
17 Jun 2021
The Role of Collaboration in Optimizing the Development of HIF Inhibitors for the Treatment of Advan
17 Jun 2021
Crystal Pharmatech is pleased to announce our new webinar series: "Molecules-to-Medicine: Accelerating Drug Development through Collaboration". Purpose: To communicate the extraordinary ingenuity taking place in 21st century drug discovery and development and that a good idea is just the first step in creating a medicine. In a nutshell, why CMC matters and how collaboration can accelerate development. Presenters: Innovative pharmaceutical scientists and entrepreneurs showcasing novel therapeutic technologies with a focus on how a molecule becomes a medicine.